| Consequences of Dysphagia |
|
|
Poor medication compliance and concordanceDysphagia can affect people of any age and has many root causes, but the problems it causes are the same. Patients with dysphagia have difficulty swallowing solid dose medication - thus they may often miss out on much-needed medicine. Overall some 45% of prescription medicines are not taken as directed with some 20% of medicines never being taken at all (Parry 2005). In a recent pilot study conducted in community pharmacies across the UK where patients over the age of 65 were asked if they had problems swallowing their medication (Greener & Ferguson 2005):
Equally, older patients who are at home and who are on medication may well have experienced difficulties with medication compliance. It is an all too frequent event that when an older patient is admitted to hospital or to a residential or nursing home they are accompanied by a carrier bag full of the last two years medication that for one reason or another has not been taken. "Repeat" medication may have been ordered religiously on a monthly basis however this is no guarantee that these medicines are taken (Greenwall, 2003). Tablet crushingWhen faced with the pain and discomfort of dysphagia, people often feel their only alternative is to crush tablets or open capsules and mix the contents in food or drink in order to receive their prescribed medicine. A recent survey found (Preston & Morris 2005):
Such routes of administration occur in over 80% of nursing homes on a weekly basis (Wright, 2002).
Changing the physical form can render a medicine 'unlicensed', making it ineffective or indeed harmful.
Opening or crushing sustained, modified or controlled release medicines can radically alter pharmacokinetic and pharmacodynamic profiles. This often results in poor efficacy and/or adverse drug reactions (ADRs). There are certain formulations that should not be opened or crushed prior to administration (Greenwall, 2003). The crushing, opening or breaking of medicines that have carcinogenic properties (antineoplastics) may not only alter the delivery mechanism, but can lead to unwanted airborne release of particles, thus exposing the administrator to the dangers or cytotoxic activity. An example is Tamoxifen, which is routinely prescribed in breast cancer management (Wright, 2002). The view of the Royal Pharmaceutical Society of Great Britain on crushing tablets is clear.
"If a formulation is tampered with then the product will be unlicensed. Pharmacists must consider and advise on the potential for distortion of bioavailability profile of the medicine" http://www.rosemontpharma.com/healthcare-section-consequences-dysphagia.html
» No Comments
There are no comments up to now.
» Post Comment
|
| Next > |
|---|